Jazz Pharmaceuticals to Report 2017 Third Quarter Financial Results on November 7, 2017

On October 24, 2017 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that it will report its 2017 third quarter financial results on Tuesday, November 7, 2017, after the close of the financial markets (Press release, Jazz Pharmaceuticals, OCT 24, 2017, View Source [SID1234521128]). Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST/9:30 p.m. GMT to discuss third quarter 2017 financial results and provide a business and financial update.

Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for one week.

Audio webcast/conference call:
U.S. Dial-In Number: +1 855 353 7924
International Dial-In Number: +1 503 343 6056
Passcode: 95499424

A replay of the conference call will be available through November 14, 2017 and accessible through one of the following telephone numbers, using the passcode below:

Replay U.S. Dial-In Number: +1 855 859 2056
Replay International Dial-In Number: +1 404 537 3406
Passcode: 95499424

Myriad to Announce Fiscal First-Quarter 2018 Financial Results on November 7, 2017

On October 24, 2017 Myriad Genetics, Inc. (NASDAQ: MYGN) reported that it will hold its fiscal first-quarter 2018 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on Tuesday, November 7, 2017 (Press release, Myriad Genetics, OCT 24, 2017, View Source [SID1234521129]). During the call, Mark C. Capone, president and CEO and Bryan Riggsbee, CFO, will provide an overview of Myriad’s financial performance for the fiscal first-quarter and provide a business update.

To listen to the call, interested parties in the United States may dial 800-701-6414 or +1 303-223-4376 for international callers. All callers will be asked to reference reservation number 21859999. The conference call also will be available through a live webcast and a slide presentation pertaining to the earnings call will also be available under the investor section of our website at www.myriad.com. A replay of the call will be available two hours after the end of the call for seven days and may be accessed by dialing 800-633-8284 within the United States or +1 402-977-9140 for international callers and entering reservation number 21859999.

Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2017 Results

On October 24, 2017 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) reported that the Company will report third quarter 2017 results after the Nasdaq market close on November 1, 2017 (Press release, Neurocrine Biosciences, OCT 24, 2017, View Source [SID1234521131]). Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update that day at 5:00pm Eastern Time (2:00pm Pacific Time).

Participants can access the live conference call by dialing 866-831-8713 (US) or 203-518-9713 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company’s website at View Source

If you are unable to attend the webcast and would like further information on this announcement, please contact the Investor Relations Department at IR@neurocrine.com. A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 800-839-4013 (US) or 402-220-2982 (International) using the conference ID: NBIX. The call will be archived for one month.

OncoMed Pharmaceuticals to Report Third Quarter Financial Results and Operational Highlights on November 2nd, 2017

On October 24, 2017 OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, reported that the Company will report third quarter 2017 financial results and operational highlights on Thursday November 2nd, 2017 (Press release, OncoMed, OCT 24, 2017, View Source [SID1234521132]). OncoMed management will host a conference call and webcast at 4:30 p.m. Eastern Time (ET) / 1:30 p.m. Pacific Time (PT).

Analysts and investors can participate in the conference call by dialing 1-(855) 420-0692 (domestic) and 1-(484) 756-4194 (international) using the conference ID# 4699289. The webcast of the conference call can be accessed live on the Investor Relations section of the OncoMed website, View Source, and will be available for replay through February 28th, 2018.

An audio replay of the conference call can be accessed by dialing 1-(855) 859-2056 (domestic) or 1-(404) 537-3406 (international) utilizing the conference ID number listed above.

Supernus to Host Third Quarter 2017 Earnings Conference Call

On October 24, 2017 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that the Company expects to report the financial results for the third quarter of 2017 after 5:00 PM ET on Monday, November 6, 2017 (Press release, Supernus, OCT 24, 2017, View Source [SID1234521133]).

Jack Khattar, President and Chief Executive Officer, and Greg Patrick, Chief Financial Officer, will host a conference call to present the third quarter 2017 business results on Tuesday, November 7, 2017 at 9:00 AM ET. Following the management presentation, the call will be open for questions.

A live webcast will be available at www.supernus.com.

Please refer to the information below for conference call dial-in information. Callers should dial in approximately 10 minutes prior to the start of the call.

Conference dial-in: (877) 288-1043
International dial-in: (970) 315-0267
Conference ID: 2899017
Conference Call Name: Supernus Pharmaceuticals 3Q 2017 Earnings Conference Call
Following the live call, a replay will be available on the Company’s website under the ‘Investors’ section. The webcast will be available on the Company’s website for 60 days following the live call.